M. Periasamy et al.
FULL PAPER
HRMS (ESI): m/z calcd. for C13H24N2O2 [M + H+] 240.1838;
found 241.1917.
and the mixture was stirred and heated to reflux for 12 h. After
cooling to room temperature, the mixture was filtered to remove
K2CO3 and the solvent was evaporated under reduced pressure.
The residue was extracted with CH2Cl2 (80 mL) and water (20 mL),
and the combined organic extract was washed with brine (20 mL)
and dried with anhydrous Na2SO4. The solvent was evaporated and
the residue was purified by column chromatography, to afforded 16
(3.148 g, 82%) as a colorless liquid; Rf = 0.7 (silica gel; hexane/
EtOAc, 95:5); [α]2D5 = 21.61 (c = 0.70, CHCl3). 1H NMR(400 MHz,
CDCl3): δ = 7.39–7.25 (m, 5 H), 4.18–4.14 (d, J = 16.0 Hz, 1 H),
3.71–3.65 (m, 1 H), 3.32–3.25 (m, 2 H), 2.90–2.86 (d, J = 16.0 Hz,
1 H), 2.72–2.60 (m, 2 H), 2.05–2.03 (m, 1 H), 1.70 (s, 2 H), 1.48–
1.45 (s, 9 H), 1.30 (s, 3 H), 1.16 (s, 2 H), 1.07 (s, 3 H), 0.84 (s, 3
H) ppm. 13C NMR (100 MHz, CDCl3): δ = 156.5, 139.5, 128.3,
127.9, 126.8, 79.5, 72.4, 71.9, 63.2, 59.2, 53.6, 50.6, 50.0, 45.8, 43.1,
tert-Butyl 4-Benzyl-octahydroquinoxaline-1-carboxylate (13): To a
solution of 12 (1.50 g, 6.25 mmol) in acetonitrile (30 mL) was
added benzyl bromide (0.83 mL,7 mmol), K2CO3 (1.79 g,13 mmol),
and KI (0.498), and the mixture was stirred and heated to reflux for
12 h. After cooling to room temperature, the mixture was filtered
to remove K2CO3 and the solvent was evaporated under reduced
pressure. The residue was extracted with CH2Cl2 (2ϫ 40 mL) and
water (20 mL) and the combined organic extract was washed with
brine (20 mL) and dried with anhydrous Na2SO4. The solvent was
evaporated and the residue was purified by column chromatog-
raphy on silica gel (100–200 mesh; hexane/EtOAc, 50:50) to afford
13 (1.78 g, 86%) as a colorless liquid. We proceeded to next step
without further purification of this product. Rf = 0.6 (silica gel;
hexane/EtOAc, 50:50); [α]2D5 = –71.07 (c = 0.45, CHCl3). 1H
NMR(400 MHz, CDCl3): δ = 7.29–7.28 (d, J = 4.4 Hz, 4 H), 7.23–
7.21 (m, 1 H), 4.01–3.98 (d, J = 13.2 Hz, 1 H), 3.63–3.57 (m, 1 H),
2.82–2.76 (m, 1 H), 2.45–2.40 (m, 1 H), 2.34–2.28 (m, 1 H), 2.21
(s, 2 H), 1.77–1.75 (d, J = 8.8 Hz, 3 H), 1.45 (s, 9 H), 1.32–1.27
(m, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 155.2, 139.4,
128.7, 128.1, 126.7, 79.2, 62.2, 61.9, 56.7, 51.8, 42.9, 30.7, 30.5,
36.0, 28.5, 26.8, 22.3, 20.5, 20.2, 14.5 ppm. IR (neat): ν = 2953,
˜
2887, 2814, 2781, 1691, 1602, 1477, 1452, 1371, 1294, 1232, 1174,
1143, 1109, 1080, 1032, 987 cm–1. HRMS (ESI): m/z calcd. for
C24H36N2O2 [M + H+] 384.2777; found 385.2854.
1-Benzyl-5,9,9-trimethyl-decahydro-5,8-methanoquinazoline (4c): To
a solution of 16 (3.072 g, 8.0 mmol) in 1,4-dioxane (20 mL), 6 m
HCl (5 mL) was added slowly by using a syringe over 15 min under
an N2 atmosphere. The resulting mixture was stirred at room tem-
perature for 12 h, then the solvent was evaporated and the residue
was neutralized with 6 n NaOH solution. The organic layer was
extracted with CH2Cl2 and the combined organic extract was
washed with brine (20 mL) and dried with anhydrous Na2SO4. The
solvent was evaporated and the residue was purified by column
chromatography to afford the 4c (2.090 g, 92%) as a yellow liquid;
Rf = 0.4 (silica gel; hexane/EtOAc, 50:50); [α]2D5 = 11.15 (c = 0.44,
CHCl3). 1H NMR(400 MHz, CDCl3): δ = 7.36–7.23 (m, 3 H),
4.34–4.30 (d, J = 16.0 Hz, 1 H), 2.94–2.91 (m, 2 H), 2.80–2.74 (m,
2 H), 2.64–2.60 (m, 1 H), 2.25–2.23 (d, J = 8.0 Hz, 1 H), 1.82–1.78
(m, 2 H), 1.71–1.70 (d, J = 4.0 Hz, 1 H), 1.56 (s, 3 H), 1.46–1.44
(m, 1 H), 1.23–1.18 (m, 2 H), 1.09 (s, 3 H), 0.86 (s, 3 H) ppm. 13C
NMR (100 MHz, CDCl3): δ = 140.2, 128.4, 128.2, 128.1, 126.6,
76.2, 61.1, 61.0, 50.9, 50.4, 50.1, 47.4, 41.6, 37.0, 27.1, 22.3, 21.1,
28.5, 25.6, 25.2 ppm. IR (neat): ν = 3084, 3068, 3030, 2975, 2931,
˜
2854, 2794, 1693, 1446, 1402, 1353, 1282, 1249, 1161, 1013, 849,
734, 695 cm–1. HRMS (ESI): m/z calcd. for C20H30N2O2 [M + Na+]
330.2307; found 353.2206.
1-Benzyl-decahydroquinoxaline (4b): To 13 (5.5 mmol 1.83 g) in 1,4-
dioxane (20 mL), 6 m HCl (5 mL) was added slowly by using a
syringe over 15 min under an N2 atmosphere. The resulting mixture
was stirred for 12 h at room temperature, then the solvent was evap-
orated and the residue was neutralized with 6 n NaOH solution
and the organic layer was extracted with CH2Cl2. The combined
organic extract was washed with brine (20 mL) and dried with an-
hydrous Na2SO4. The solvent was evaporated and the residue was
purified by chromatography on basic alumina (100–200 mesh; hex-
ane/EtOAc, 50:50) to obtain 4b (1.16 g, 90%) as a colorless solid;
Rf = 0.2 (silica gel; hexane/EtOAc, 50:50); m.p. 95–96 °C; [α]2D5
=
15.5 ppm. IR (neat): ν = 3281, 3076, 2934, 1554, 1485, 1415, 1379,
–109.81 (c = 0.52, CHCl3). 1H NMR(400 MHz, CDCl3): δ = 7.31–
7.30 (d, J = 4.4 Hz, 4 H), 7.26 (s, 1 H), 4.13–4.10 (d, J = 13.2 Hz,
1 H), 3.16–3.12 (d, J = 13.2 Hz, 1 H), 2.94–2.84 (m, 2 H), 2.73–
2.70 (d, J = 11.6 Hz, 1 H), 2.48–2.42 (m, 1 H), 2.27–2.23 (d, J =
13.2 Hz, 1 H), 2.12 (dt, J = 11.2, 4 Hz, 1 H), 1.87–1.78 (m, 2 H),
1.72–1.70 (d, J = 7.2 Hz, 2 H), 1.38–1.13 (m, 5 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 139.0, 129.1, 128.1, 126.7, 67.0, 60.4, 57.3,
˜
1147, 1055, 808, 692 cm–1. HRMS (ESI): m/z calcd. for C19H28N2
[M + H+] 284.2252; found 285.2329.
Phenyl-(5,9,9-trimethyl-octahydro-5,8-methanoquinazolin-1-yl)meth-
anone (17): To a solution of chiral piperazine 14 (1.940 g, 10 mmol)
and trimethylamine (1.36 mL, 10.0 mmol) in CH2Cl2 (100 mL),
benzoyl chloride (1.270 mL, 10 mmol) was added at –78 °C slowly
(for 30 min) by using a syringe under an N2 atmosphere. The reac-
tion mixture was brought to room temperature slowly and further
stirred for 12 h. Upon completion of the reaction (monitored by
TLC), the solvent was evaporated under reduced pressure and the
residue was washed with NaHCO3. Purification of the residue by
column chromatography afforded 17 (2.771 g, 93%) as a brown
solid. Rf = 0.6 (silica gel; hexane/EtOAc, 60:40); [α]2D5 = 38.67 (c =
0.60, CHCl3). 1H NMR(400 MHz, CDCl3): δ = 7.38–7.28 (m, 5 H),
4.02–3.98 (q, J = 16.0 Hz, 1 H), 3.80–3.78 (d, J = 12.0 Hz, 1 H),
3.50–3.45 (t, J = 20.0 Hz, 1 H), 3.08–3.06 (d, J = 8.0 Hz, 2 H),
2.82–2.79 (d, J = 12.0 Hz, 1 H), 2.57–2.48 (m, 2 H),1.92 (s, 1 H),
1.47–1.45 (t, J = 12.0 Hz, 1 H), 1.20 (s, 4 H), 1.10–1.04 (m, 2 H),
0.84 (s, 3 H), 0.74 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ
= 173.0, 137.2, 131.7, 129.6, 128.2, 127.9, 127.1, 66.2, 60.2, 58.4,
51.2, 48.6, 48.0, 45.8, 42.9, 35.4, 26.5, 21.8, 20.8, 14.1, 11.4 ppm.
53.7, 46.0, 32.8, 29.0, 25.2, 24.9 ppm. IR (KBr): ν = 3254, 3046,
˜
3030, 2980, 2904, 2854, 2794, 1605, 1512, 1446, 1347, 1309, 1254,
1150, 1128, 1084, 1073, 1052, 1002, 827, 756 cm–1. HRMS (ESI):
m/z calcd. for C15H22N2 [M + H+] 230.1783; found 231.1861.
tert-Butyl 4-Benzyl-5,9,9-trimethyl-octahydro-5,8-methanoquinazol-
ine-1-carboxylate (16): To a solution of chiral camphanylpiperazine
14 (1.940 g, 10 mmol) in CH2Cl2 (100 mL), di-tert-butyldicar-
bonate (2.2 mL, 10 mmol) was added at 0 °C slowly (for 10 min)
by using a syringe under an N2 atmosphere. The reaction mixture
was brought to room temperature slowly and further stirred for
6 h. Upon completion of the reaction (monitored by TLC), the
solvent was evaporated under reduced pressure. Purification of the
residue by column chromatography on silica gel (100–200 mesh;
hexane/EtOAc, 50:50) afforded tert-butyl 5,9,9-trimethyl-octahy-
dro-5,8-methanoquinzoline-1-carboxylate 15 (2.941 g, 10 mmol) as
a colorless viscous liquid. To a solution of 15 (2.941 g, 10 mmol)
in anhydrous acetonitrile (30 mL) was added benzyl bromide
IR (KBr): ν = 3314, 3079, 3062, 3024, 2947, 2887, 2739, 1610, 1577,
˜
1445, 1402, 1237, 1160, 1122, 1023, 793 cm–1. HRMS (ESI): m/z
(0.83 mL, 7 mmol), K2CO3 (1.79 g, 13 mmol), and KI (0.498 g), calcd. for C19H26N2O [M + H+] 298.2045; found 299.2123.
6074
www.eurjoc.org
© 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2014, 6067–6076